Johnson & Johnson
JNJ: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|>J | LOCK|?v> | LOCK|B<j<Z> |
Johnson & Johnson: Maintaining Our $164 Fair Value Estimate Despite New Talc Litigation Strategy
Johnson & Johnson's third effort to settle talc claims through the bankruptcy system has failed, as a federal judge did not approve a $9 billion settlement, and the firm has decided to return to the tort system to litigate claims.
